Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
Director comp.
CC transcript
Appointed director
|
|
MANNKIND CORP (MNKD)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 10/03/2023 |
4/A
| Castagna Michael (CEO) has filed a Form 4 on MANNKIND CORP|
Txns:
| Sold 10,000 shares
@ $4.08, valued at
$40.8k
|
|
| 07/07/2023 |
4/A
| Form 4/A - Statement of changes in beneficial ownership of securities: [Amend] |
| 05/30/2023 |
4/A
| Binder Steven B. (CFO) has filed a Form 4 on MANNKIND CORP|
Txns:
| Paid exercise price by delivering 281,267 shares
@ $4.79, valued at
$1.3M
|
|
| 08/24/2022 |
4/A
| Castagna Michael (CEO) has filed a Form 4 on MANNKIND CORP|
Txns:
| Granted 3,147 shares
@ $2.93, valued at
$9.2k
|
|
| 08/24/2022 |
4/A
| Binder Steven B. (CFO) has filed a Form 4 on MANNKIND CORP|
Txns:
| Granted 791 shares
@ $2.93, valued at
$2.3k
|
|
| 08/24/2022 |
4/A
| Tross Stuart A (Chief People & Workpl Officer) has filed a Form 4 on MANNKIND CORP|
Txns:
| Granted 4,581 shares
@ $2.93, valued at
$13.4k
|
|
| 08/24/2022 |
4/A
| Tross Stuart A (Chief People & Workpl Officer) has filed a Form 4 on MANNKIND CORP|
Txns:
| Granted 9,225 shares
@ $2.71, valued at
$25k
|
|
| 08/24/2022 |
4/A
| Galindo Alejandro (EVP Endocrine Business Unit) has filed a Form 4 on MANNKIND CORP|
Txns:
| Granted 36,900 shares
@ $2.71, valued at
$100k
|
|
| 08/24/2022 |
4/A
| Castagna Michael (CEO) has filed a Form 4 on MANNKIND CORP|
Txns:
| Granted 27,675 shares
@ $2.71, valued at
$75k
|
|
| 08/24/2022 |
4/A
| Binder Steven B. (CFO) has filed a Form 4 on MANNKIND CORP|
Txns:
| Granted 711 shares
@ $3.17, valued at
$2.3k
|
|
| 08/24/2022 |
4/A
| Tross Stuart A (Chief People & Workpl Officer) has filed a Form 4 on MANNKIND CORP|
Txns:
| Granted 2,254 shares
@ $3.17, valued at
$7.1k
|
|
| 08/24/2022 |
4/A
| Galindo Alejandro (EVP Endocrine Business Unit) has filed a Form 4 on MANNKIND CORP|
Txns:
| Granted 5,000 shares
@ $2.93, valued at
$14.7k
|
|
| 08/24/2022 |
4/A
| Castagna Michael (CEO) has filed a Form 4 on MANNKIND CORP|
Txns:
| Granted 1,804 shares
@ $3.17, valued at
$5.7k
|
|
| 08/24/2022 |
4/A
| Galindo Alejandro (EVP Endocrine Business Unit) has filed a Form 4 on MANNKIND CORP|
Txns:
| Granted 1,804 shares
@ $3.17, valued at
$5.7k
|
|
| 05/25/2022 |
4/A
| Form 4/A - Statement of changes in beneficial ownership of securities: [Amend] |
| 02/09/2022 |
4/A
| Galindo Alejandro (Chief Commercial Officer) has filed a Form 4 on MANNKIND CORP|
Txns:
| Bought 1,804 shares
@ $3.17, valued at
$5.7k
|
|
| 02/09/2022 |
4/A
| Castagna Michael (CEO) has filed a Form 4 on MANNKIND CORP|
Txns:
| Bought 1,804 shares
@ $3.17, valued at
$5.7k
|
|
| 02/09/2022 |
4/A
| Tross Stuart A (Chief People & Workpl Officer) has filed a Form 4 on MANNKIND CORP|
Txns:
| Bought 2,254 shares
@ $3.17, valued at
$7.1k
|
|
| 12/10/2020 |
4/A
| Galindo Alejandro (Chief Commercial Officer) has filed a Form 4 on MANNKIND CORP|
Txns:
| Bought 34,602 shares
@ $2.89, valued at
$100k
|
|
| 03/13/2019 |
4/A
| Tross Stuart A (EVP, Chief People Officer) has filed a Form 4 on MANNKIND CORP|
Txns:
| Bought 14,124 shares
@ $1.77, valued at
$25k
|
|
| 03/13/2019 |
4/A
| Kendall David M (Chief Medical Officer) has filed a Form 4 on MANNKIND CORP|
Txns:
| Bought 2,824 shares
@ $1.77, valued at
$5k
|
|
| 03/13/2019 |
4/A
| McCauley Patrick (Chief Commercial Officer) has filed a Form 4 on MANNKIND CORP|
Txns:
| Bought 14,124 shares
@ $1.77, valued at
$25k
|
|
| 03/13/2019 |
4/A
| Castagna Michael (CEO) has filed a Form 4 on MANNKIND CORP|
Txns:
| Bought 25,000 shares
@ $1.77, valued at
$44.3k
|
|
| 05/22/2018 |
4/A
| NORDHOFF HENRY L (Director) has filed a Form 4 on MANNKIND CORP|
Txns:
| Granted 65,200 restricted stock units
@ $0 |
|
| 05/22/2018 |
4/A
| MacCallum David (Director) has filed a Form 4 on MANNKIND CORP|
Txns:
| Granted 65,200 restricted stock units
@ $0 |
|
| 05/22/2018 |
4/A
| KRESA KENT (Director) has filed a Form 4 on MANNKIND CORP|
Txns:
| Granted 65,200 restricted stock units
@ $0 |
|
| 05/22/2018 |
4/A
| Friedman Michael A (Director) has filed a Form 4 on MANNKIND CORP|
Txns:
| Granted 65,200 restricted stock units
@ $0 |
|
| 05/22/2018 |
4/A
| CONSIGLIO RONALD J (Director) has filed a Form 4 on MANNKIND CORP|
Txns:
| Granted 65,200 restricted stock units
@ $0 |
|
| 05/22/2018 |
4/A
| Shannon James Samuel (Director) has filed a Form 4 on MANNKIND CORP|
Txns:
| Granted 65,200 restricted stock units
@ $0 |
|
| 08/21/2012 |
4/A
| Martens Juergen (Corporate VP) has filed a Form 4 on MANNKIND CORP |
| 01/13/2011 |
4/A
| MANN ALFRED E (Chairman & CEO) has filed a Form 4 on MANNKIND CORP|
Txns:
| Bought 700,000 shares
@ $8.73, valued at
$6.1M
|
|
| 12/16/2010 |
4/A
| MANN ALFRED E (Chairman & CEO) has filed a Form 4 on MANNKIND CORP|
Txns:
| Bought 700,000 shares
@ $8.46, valued at
$5.9M
|
|
| 02/24/2010 |
4/A
| PFEFFER MATTHEW J (Corporate VP and CFO) has filed a Form 4 on MANNKIND CORP |
| 09/04/2009 |
4/A
| PFEFFER MATTHEW J (Corporate VP and CFO) has filed a Form 4 on MANNKIND CORP |
|
|
|